Chrissie Fletcher

Chrissie is the Vice President and Head for Respiratory, Immunology and Inflammation Statistics at GSK. She leads a group of statisticians supporting the development of new and approved medicines in respiratory, immunology, hepatology, infectious diseases, neuroscience, renal, HIV, and global health. Chrissie also manages a group of statisticians based in India who support the R&D portfolio. Chrissie has worked in the Pharmaceutical Industry for 34 years and she has experience of developing and commercialising new medicines in a variety of disease areas across all phases of clinical development.

Chrissie is actively engaged in statistical societies, pharmaceutical trade associations and initiatives relating to the Pharmaceutical Industry. Chrissie leads the EFSPI Statistics Leaders Forum, and she is a member of the EFPIA Clinical Research Expert Group where she co-leads the Innovation in Clinical Trials team. Chrissie leads the EFPIA/EFSPI estimand implementation working group (ICH E9(R1)) and she represents GSK on the ABPI Clinical Research Project Team.

In 2019 Chrissie was given honorary membership for her outstanding service to PSI, and she was selected for the Women in Data “Twenty in Data and Technology” award which showcases phenomenal women who encompass every level of seniority and data discipline, and who continue to make role models visible within their industry professions.

Chrissie is a Chartered Statistician of the Royal Statistical Society (RSS). Chrissie has an MSc in Applied Statistics and a BSc (Hons) in Statistics with Management Science Techniques.